Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 4321 AL 4335

LSVT® BIG versus progressive structured mobility training through synchronous telerehabilitation in Parkinson's disease: A randomized controlled trial

Kaya Aytutuldu G, Ersoz Huseyinsinoglu B, Karagoz Sakalli N, Sen A, Yeldan I.

Neurol Sci. 2024 Jul;45(7):3163-3172. doi: 10.1007/s10072-024-07322-0. Epub 2024 Jan 25.

Home-based exergaming to treat gait and balance disorders in patients with Parkinson's disease: A phase II randomized controlled trial

Nuic D, van de Weijer S, Cherif S, Skrzatek A, Zeeboer E, Olivier C, Corvol JC, Foulon P, Pastor JZ, Mercier G, Lau B, Bloem BR, De Vries NM, Welter ML.

Eur J Neurol. 2024 Jan;31(1):e16055. doi: 10.1111/ene.16055. Epub 2023 Sep 10.

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease

Jiang S, Wang H, Yang C, Feng F, Xu D, Zhang M, Xie M, Cui R, Zhu Z, Jia C, Liu L, Wang L, Yang X, Yang Y, Hao H, Liu Z, Wu Z, Leng L, Li X, Sun X, Zhao X, Xu J, Zhang Y, Wan X, Bao X, Wang R.

J Neurol Neurosurg Psychiatry. 2024 Nov 18;95(12):1102-1111. doi: 10.1136/jnnp-2023-332921.

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial

Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T, Simuni T, Postuma RB, Pavese N, Stocchi F, Brockmann K, Smigorski K, Gerbaldo V, Fontoura P, Doody R, Kerchner GA, Brundin P, Marek K, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group.

Nat Med. 2024 Dec;30(12):3669-3675. doi: 10.1038/s41591-024-03270-6. Epub 2024 Oct 8.

Effects of Blood Flow Restriction Resistance Training on Autonomic and Endothelial Function in Persons with Parkinson's Disease

Bane A, Wilson L, Jumper J, Spindler L, Wyatt P, Willoughby D.

J Parkinsons Dis. 2024;14(4):761-775. doi: 10.3233/JPD-230259.

Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms

Li G, Huang P, Cui S, He Y, Jiang Q, Li B, Li Y, Xu J, Wang Z, Tan Y, Chen S.

Parkinsonism Relat Disord. 2024 Mar;120:105978. doi: 10.1016/j.parkreldis.2023.105978. Epub 2024 Jan 12.

Improving Executive Function and Dual-Task Cost in Parkinson Disease: A Randomized Controlled Trial

Zhou JH, Wang RY, Liu YT, Cheng SJ, Liu HH, Yang YR.

J Neurol Phys Ther. 2024 Oct 1;48(4):188-197. doi: 10.1097/NPT.0000000000000489. Epub 2024 Sep 17.

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

McGarry A, Rosanbalm S, Leinonen M, Olanow CW, To D, Bell A, Lee D, Chang J, Dubow J, Dhall R, Burdick D, Parashos S, Feuerstein J, Quinn J, Pahwa R, Afshari M, Ramirez-Zamora A, Chou K, Tarakad A, Luca C, Klos K, Bordelon Y, St Hiliare MH, Shprecher D, Lee S, Dawson TM, Roschke V, Kieburtz K.

Lancet Neurol. 2024 Jan;23(1):37-45. doi: 10.1016/S1474-4422(23)00378-2.

On-Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial

Zoetewei D, Herman T, Ginis P, Palmerini L, Brozgol M, Thumm PC, Ferrari A, Ceulemans E, Decaluwé E, Hausdorff JM, Nieuwboer A.

Mov Disord. 2024 May;39(5):876-886. doi: 10.1002/mds.29762. Epub 2024 Mar 14.

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group.

Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15.

Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA.

Mov Disord. 2024 May;39(5):863-875. doi: 10.1002/mds.29768. Epub 2024 Mar 15.

Parkinson's disease variant detection and disclosure: PD GENEration, a North American study

Cook L, Verbrugge J, Schwantes-An TH, Schulze J, Foroud T, Hall A, Marder KS, Mata IF, Mencacci NE, Nance MA, Schwarzschild MA, Simuni T, Bressman S, Wills AM, Fernandez HH, Litvan I, Lyons KE, Shill HA, Singer C, Tropea TF, Vanegas Arroyave N, Carbonell J, Cruz Vicioso R, Katus L, Quinn JF, Hodges PD, Meng Y, Strom SP, Blauwendraat C, Lohmann K, Casaceli C, Rao SC, Ghosh Galvelis K, Naito A, Beck JC, Alcalay RN.

Brain. 2024 Aug 1;147(8):2668-2679. doi: 10.1093/brain/awae142.

Home physical therapy versus telerehabilitation in improving motor function and quality of life in Parkinson's disease: a randomized controlled trial

Ge Y, Zhao W, Zhang L, Zhao X, Shu X, Li J, Qiao L, Liu Y, Wang H.

BMC Geriatr. 2024 Nov 22;24(1):968. doi: 10.1186/s12877-024-05529-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias